Literature DB >> 6577802

Carbamazepine in the treatment of bulimia.

A S Kaplan, P E Garfinkel, P L Darby, D M Garner.   

Abstract

Of six bulimic outpatients who completed a double-blind crossover trial with carbamazepine, one patient, who had a history suggestive of bipolar disorder, responded dramatically with cessation of binge eating. This supports a possible link in some patients between bulimia and affective illness.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6577802     DOI: 10.1176/ajp.140.9.1225

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  9 in total

Review 1.  Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge-eating disorder.

Authors:  S Krüger; S H Kennedy
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

2.  Bulimia in a patient with temporal lobe epilepsy.

Authors:  B R Ott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

Review 3.  Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Francisco Romo-Nava
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

Review 4.  Current perspectives on drug therapies for anorexia nervosa and bulimia nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

Review 5.  Eating disorders in children and adolescents: pharmacological therapies.

Authors:  L A Kotler; B T Walsh
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 6.  Anorexia nervosa and bulimia nervosa.

Authors:  D S Goldbloom; S H Kennedy; A S Kaplan; D B Woodside
Journal:  CMAJ       Date:  1989-05-15       Impact factor: 8.262

Review 7.  Role of antiepileptic drugs in the management of eating disorders.

Authors:  Susan L McElroy; Anna I Guerdjikova; Brian Martens; Paul E Keck; Harrison G Pope; James I Hudson
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

8.  Advances in the Treatment of Anorexia Nervosa and Bulimia Nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

9.  Review of the use of Topiramate for treatment of psychiatric disorders.

Authors:  Danilo Arnone
Journal:  Ann Gen Psychiatry       Date:  2005-02-16       Impact factor: 3.455

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.